文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期拔管后无创通气与标准拔管对低氧性非高碳酸血症患者有创机械通气时长的影响:随机对照试验的系统评价与个体患者数据荟萃分析

Effects of early extubation followed by noninvasive ventilation versus standard extubation on the duration of invasive mechanical ventilation in hypoxemic non-hypercapnic patients: a systematic review and individual patient data meta-analysis of randomized controlled trials.
PubMed 文献 · Crit Care · 2021-06-01
一句话结论在低氧性非高碳酸血症急性呼吸衰竭患者中,早期拔管后行无创通气较标准脱机可缩短有创机械通气时间(平均差-3.43天,95%CI -5.17至-1.69,p<0.001)。

该系统评价与个体患者数据荟萃分析检索EMBASE、Medline和Cochrane Central Register of Controlled Trials,纳入截至2020年10月发表的随机对照试验,最终纳入6项研究、459例低氧性非高碳酸血症急性呼吸衰竭恢复期患者(干预组233例,对照组226例)。早期拔管后无创通气组较标准脱机组有创机械通气时间更短(平均差-3.43天,95%CI -5.17至-1.69,p<0.001),总机械通气时间更短(平均差-2.04天,95%CI -3.82至-0.27,p=0.024),呼吸机相关性肺炎风险降低(OR 0.24,95%CI 0.08至0.71,p=0.014),ICU时间(时间比0.81,95%CI 0.68至0.96,p=0.015)和住院时间(时间比0.81,95%CI 0.69至0.95,p=0.010)缩短,ICU死亡率无差异。作者认为,尽管原始研究有限,早期拔管后无创通气似乎有助于减少有创机械通气总天数。

要点

  • 低氧性非高碳酸血症急性呼吸衰竭恢复期患者早期拔管后行无创通气,有创机械通气时间较标准脱机缩短(平均差-3.43天,95%CI -5.17至-1.69,p<0.001)。
  • 早期拔管后无创通气组总机械通气时间较对照组缩短(平均差-2.04天,95%CI -3.82至-0.27,p=0.024)。
  • 早期拔管后无创通气组呼吸机相关性肺炎风险较对照组降低(OR 0.24,95%CI 0.08至0.71,p=0.014)。
  • 早期拔管后无创通气组ICU时间(时间比0.81,95%CI 0.68至0.96,p=0.015)和住院时间(时间比0.81,95%CI 0.69至0.95,p=0.010)较对照组缩短。
  • 两组ICU死亡率无差异。

适用人群与场景

  • 成人低氧性非高碳酸血症急性呼吸衰竭恢复期患者,纳入随机对照试验中早期拔管后接受无创通气并与常规脱机比较者。

研究设计与关键结果

  • 个体患者数据荟萃分析,检索EMBASE、Medline和Cochrane Central Register of Controlled Trials,纳入截至2020年10月发表的随机对照试验,共筛查1605条记录,6项研究纳入定量合成,459例患者(平均[SD]年龄62[15]岁;269例[59%]男性)纳入分析(干预组233例,对照组226例)。
  • 早期拔管后无创通气组较对照组有创机械通气时间缩短(平均差-3.43天,95%CI -5.17至-1.69,p<0.001)。
  • 早期拔管后无创通气组较对照组总机械通气时间缩短(平均差-2.04天,95%CI -3.82至-0.27,p=0.024)。
  • 早期拔管后无创通气组较对照组呼吸机相关性肺炎风险降低(OR 0.24,95%CI 0.08至0.71,p=0.014)。
  • 早期拔管后无创通气组较对照组ICU时间缩短(时间比0.81,95%CI 0.68至0.96,p=0.015)。
  • 早期拔管后无创通气组较对照组住院时间缩短(时间比0.81,95%CI 0.69至0.95,p=0.010)。
  • 两组ICU死亡率无差异。

证据类型、等级与局限

  • 证据类型:随机对照试验的系统评价与个体患者数据荟萃分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管原始研究有限,采用个体患者数据荟萃分析方法,早期拔管后无创通气似乎有助于减少低氧性非高碳酸血症急性呼吸衰竭患者的有创机械通气总天数。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Usefulness of noninvasive ventilation (NIV) in weaning patients with non-hypercapnic hypoxemic acute respiratory failure (hARF) is unclear. The study aims to assess in patients with non-hypercapnic hARF, the efficacy of NIV after early extubation, compared to standard weaning.

METHODS: In this individual patient data meta-analysis, we searched EMBASE, Medline and Cochrane Central Register of Controlled Trials to identify potentially eligible randomized controlled trials published from database inception to October 2020. To be eligible, studies had to include patients treated with NIV after early extubation and compared to conventional weaning in adult non-hypercapnic hARF patients. Anonymized individual patient data from eligible studies were provided by study investigators. Using one-step and two-step meta-analysis models we tested the difference in total days spent on invasive ventilation.

RESULTS: We screened 1605 records. Six studies were included in quantitative synthesis. Overall, 459 participants (mean [SD] age, 62 [15] years; 269 [59%] males) recovering from hARF were included in the analysis (233 in the intervention group and 226 controls). Participants receiving NIV had a shorter duration of invasive mechanical ventilation compared to control group (mean difference, - 3.43; 95% CI - 5.17 to - 1.69 days, p < 0.001), a shorter duration of total days spent on mechanical ventilation (mean difference, - 2.04; 95% CI - 3.82 to - 0.27 days, p = 0.024), a reduced risk of ventilatory associated pneumonia (odds ratio, 0.24; 95% CI 0.08 to 0.71, p = 0.014), a reduction of time spent in ICU (time ratio, 0.81; 95% CI 0.68 to 0.96, p = 0.015) and in-hospital (time ratio, 0.81; 95% CI 0.69 to 0.95, p = 0.010), with no difference in ICU mortality.

CONCLUSIONS: Although primary studies are limited, using an individual patient data metanalysis approach, NIV after early extubation appears useful in reducing total days spent on invasive mechanical ventilation.

TRIAL REGISTRATION: The protocol was registered to PROSPERO database on 12/06/2019 and available at PROSPERO website inserting the study code i.e., CRD42019133837.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Vaschetto R, Pecere A, Perkins GD, et al. Effects of early extubation followed by noninvasive ventilation versus standard extubation on the duration of invasive mechanical ventilation in hypoxemic non-hypercapnic patients: a systematic review and individual patient data meta-analysis of randomized controlled trials. Crit Care. 2021. PMID: 34074314. doi:10.1186/s13054-021-03595-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。